Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway
Caifu Lu, Cong Zhang
Topics & Concepts
Cancer researchCXCL11MedicinePI3K/AKT/mTOR pathwayVimentinProtein kinase BInternal medicineBiologySignal transductionCell biologyChemokineReceptorChemokine receptorImmunohistochemistryChemokine receptors and signalingColorectal Cancer Treatments and StudiesCancer Cells and Metastasis